Get started
Author

Kefah Ali Alqawasmeh

Observed names: Alqawasmeh, Kefah, Kefah Ali Al Alqawasmeh, Kefah Alqawasmeh
ORCID: 0009-0004-9854-4598
Observed ORCID: 0009-0004-9854-4598
OpenAlex ID: A5116616283
Facilitators and barriers to generic and biosimilar medications in the Middle East and North Africa: insights from physicians and pharmacists—a systematic review
2025 · Kefah Ali Alqawasmeh, Thomas Mason, et al. · European Journal of Clinical Pharmacology · 17
Policy dialogue on health technology assessment in Middle East and North Africa: reporting from an HTAi initiative
2026 · Mouna Jameleddine, Antonio Migliore, et al. · International Journal of Technology Assessment in Health Care · 2
PDF
Healthcare Professionals' Perceptions of Generic and Biosimilar Medicines in Abu Dhabi
2026 · Alqawasmeh, Kefah · Lancaster EPrints (Lancaster University)
PDF
Healthcare Professionals’ Insights Towards Implementing Generic and Biosimilar Medicines’ Policies: A Mixed Methods Study Protocol
2026 · Kefah Alqawasmeh, Thomas Masson, et al. · Research Square
PDF
HPR160 Physicians' and Pharmacists’ Views on Implementing Generic Medicines Standard and Biosimilar Guide
2025 · Kefah Ali Alqawasmeh, Thomas Mason, et al. · Value in Health
Works count: 5
Citation count: 19
H-index: 2
I10-index: 1
Year
Topic
Type